Search Results 41-50 of 21094 for Hepatitis C
Immunologists and virologists also are working on making a hepatitis C vaccine. Another area of research is cell transplant. This involves putting liver cells, ...
Hepatocellular carcinoma happens most often in people with chronic liver conditions, such as cirrhosis caused by hepatitis B or hepatitis C infection.
Hepatitis C infection accounts for two-thirds of newly diagnosed chronic liver disease cases and 40 percent of liver transplants. For this study, Mayo Clinic ...
An extensive investigation into hepatitis C infections in three transplant patients led investigators to uncover the route of transmission.
Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...
Mayo Clinic doctors and researchers are studying new ways to diagnose and treat hepatitis C, with particular emphasis on optimal antiviral therapy before and ...
Hepatitis C virus (HCV) infection can lead to cirrhosis and its related complications, hepatocellular carcinoma (HCC), liver failure and death.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.